United States Growth Factors Market to Reach USD 4.07 Billion by 2033, Led by Merck, Thermo Fisher, and Lonza | DataM Intelligence

The global Growth Factors Market reached USD 2.19Billion in 2024 and is projected to reach USD 4.07 billion by 2033, growing at a CAGR of 7.1% during the forecast period 2025-2033, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, The FDA approved a novel growth factor-based therapy for chronic wound healing, demonstrating significant efficacy in diabetic foot ulcers.
✅ In October 2025, A leading US biotech company launched a new recombinant growth factor for orthopedic applications, enhancing bone regeneration.
✅ In October 2025, The National Institutes of Health allocated $150 million for growth factor research in neurodegenerative diseases.

Japan: Recent Industry Developments

✅ In October 2025, Japan's Pharmaceuticals and Medical Devices Agency approved a new growth factor formulation for cartilage repair in osteoarthritis patients.
✅ In October 2025, Takeda Pharmaceutical expanded its growth factor production facility to meet increasing global demand for regenerative medicine products.
✅ In October 2025, A Japanese research consortium developed a novel growth factor delivery system for targeted cancer therapy.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/growth-factors-market?jd

Market Trends & Drivers

The Growth Factors Market is experiencing robust growth driven by advancements in regenerative medicine, increasing prevalence of chronic diseases, and rising applications in cell culture and biopharmaceutical production. Key trends include the development of recombinant growth factors, expansion in personalized medicine, and growing adoption in wound care and orthopedic applications. Technological innovations in production methods and purification processes, coupled with increasing research investments, are significantly accelerating market expansion.

Competitive Landscape

The market features strong competition among biotechnology companies, pharmaceutical giants, and specialized growth factor manufacturers.

Merck KGaA leads with comprehensive growth factor portfolios for research and therapeutic applications through its MilliporeSigma division.
Thermo Fisher Scientific Inc. provides extensive growth factor products for cell culture and bioprocessing applications.
Lonza Group AG specializes in growth factors for cell and gene therapy manufacturing and biopharmaceutical production.
Sartorius AG offers advanced growth factor solutions for bioprocessing and cell culture applications.
Danaher Corporation provides growth factor products through its Pall and Cytiva life science platforms.
Roche Holding AG develops therapeutic growth factors for oncology and hematology applications.
Novartis AG focuses on growth factor-based therapies for regenerative medicine and specialized treatments.
Johnson & Johnson advances growth factor applications in wound healing and orthopedic medicine.
Smith & Nephew plc specializes in growth factor technologies for advanced wound care applications.
Medtronic plc develops growth factor-based products for spinal and orthopedic surgical applications.

Segmentation

By Type (Vascular Endothelial Growth Factor (VEGF), Epidermal Growth Factor (EGF), Fibroblast Growth Factor (FGF), Platelet-derived Growth Factor (PDGF), Insulin-like Growth Factor (IGF), Others)
By Application (Oncology, Dermatology & Wound Healing, Cardiovascular Disorders, Neurological Disorders, Orthopedics, Others)
By End-User (Hospitals & Clinics, Biopharmaceutical Companies, Research & Academic Institutes, Contract Research Organizations (CROs))

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/growth-factors-market?jd

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us:

At DataM Intelligence, we provide more than just data-we deliver end-to-end business solutions. From deep-dive research to strategic consulting, we partner with you to turn complex market trends into a clear competitive advantage.

Leveraging our extensive database of 6,300+ reports across 40+ domains, we offer the insights and astute recommendations you need to make confident decisions. We are proud to support 200+ companies worldwide in navigating their key business challenges and accelerating their growth trajectory.

This release was published on openPR.